Please use this identifier to cite or link to this item:
https://hdl.handle.net/2445/217206| Title: | Esophageal involvement in DPP4 inhibitor-associated bullous pemphigoid |
| Author: | Brufau Cochs, Magí Alamon Reig, Francesc Luque Luna, Mar Bosch Amate, Xavier Moreta, Maria José Bassegoda, Octavi Mascaró Galy, José Manuel |
| Keywords: | Dermatologia Diabetis Pèmfig Dermatology Diabetes Pemphigus |
| Issue Date: | 13-Oct-2023 |
| Publisher: | John Wiley & Sons |
| Abstract: | Dipeptidyl-peptidase 4 inhibitors (DPP4i) are widely used hypoglycemic drugs strongly associated with bullous pemphigoid (BP), the most common autoimmune subepidermal blistering disease. DPP4i-associated BP may display differences in histological, immunological, and clinical features. Here we present the case of a patient treated with DPP4i who developed a severe BP involving both the skin and esophagus. |
| Note: | Reproducció del document publicat a: https://doi.org/10.1111/ddg.15304 |
| It is part of: | JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2023, vol. 22, num.3, p. 430-432 |
| URI: | https://hdl.handle.net/2445/217206 |
| Related resource: | https://doi.org/10.1111/ddg.15304 |
| ISSN: | 1610-0379 |
| Appears in Collections: | Articles publicats en revistes (Medicina) |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 870373.pdf | 1.14 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License
